(Q35676417)

9 August 2017

Drug-induced liver injury associated with the use of nonnucleoside reverse-transcriptase inhibitors (English)

1 reference

9 August 2017

Douglas T Dieterich

1

1 reference

9 August 2017

Patrick A Robinson

series ordinal

2

1 reference

9 August 2017

James Love

series ordinal

3

1 reference

9 August 2017

Jerry O Stern

series ordinal

4

1 reference

9 August 2017

language of work or name

English

0 references

publication date

1 March 2004

1 reference

Clinical Infectious Diseases

9 August 2017

1 reference

9 August 2017

38 Suppl 2

1 reference

9 August 2017

S80-9

1 reference

Lack of hepatotoxicity associated with nonnucleoside reverse transcriptase inhibitors

9 August 2017

1 reference

Drug-induced hepatotoxicity.

21 January 2018

1 reference

Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections

21 January 2018

1 reference

Hepatotoxicity associated with antiretroviral therapy in adults infected with human immunodeficiency virus and the role of hepatitis C or B virus infection

21 January 2018

1 reference

A comprehensive hepatic safety analysis of nevirapine in different populations of HIV infected patients

21 January 2018

1 reference

Incidence of and risk factors for severe hepatotoxicity associated with antiretroviral combination therapy

21 January 2018

1 reference

Hepatotoxicity in HIV-1-infected patients receiving nevirapine-containing antiretroviral therapy

21 January 2018

1 reference

Liver toxicity caused by nevirapine

21 January 2018

1 reference

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1086/381450

1 reference

9 August 2017

1 reference